NCT00459173View on ClinicalTrials.gov

Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation

PHASE3CompletedINTERVENTIONAL

Enrollment

4,850

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

Maintenance of Smoking Cessation

Interventions

DRUG

rimonabant (SR141716)

Trial Locations (3)

08807

Sanofi-Aventis, Bridgewater

Unknown

Sanofi-Aventis, Cove

Sanofi-Aventis, Laval

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY